• 1
    Pradalier A, Auray JP, El Hasnaoui A, et al.Economic impact of migraine and other episodic headaches in France: Data from the GRIM2000 study. Pharmacoeconomics. 2004;22:985-999.
  • 2
    Bigal ME, Rapoport AM, Bordini CA, Tepper SJ, Sheftell FD, Speciali JG. Burden of migraine in Brazil: Estimate of cost of migraine to the public health system and an analytical study of the cost-effectiveness of a stratified model of care. Headache. 2003;43:742-754.
  • 3
    Lambert J, Carides GW, Meloche JP, Gerth WC, Marentette MA. Impact of migraine symptoms on health care use and work loss in Canada in patients randomly assigned in a phase III clinical trial. Can J Clin Pharmacol. 2002;9:158-164.
  • 4
    Gerth WC, Carides GW, Dasbach EJ, Visser WH, Santanello NC. The multinational impact of migraine symptoms on healthcare utilisation and work loss. Pharmacoeconomics. 2001;19:197-206.
  • 5
    Diamond ML. The role of concomitant headache types and non-headache co-morbidities in the under-diagnosis of migraine. Neurology. 2002;58:S3-S9.
  • 6
    Harpole LH, Samsa GP, Jurgelski AE, Shipley JL, Bernstein A, Matchar DB. Headache management program improves outcome for chronic headache. Headache. 2003;43:715-724.
  • 7
    Okuma H, Kitagawa Y, Takagi S. Clinical efficacy of rizatriptan for patients with migraine: Efficacy of drug therapy for migraine accompanied by tension headache-like symptoms focusing on neck stiffness. J Headache Pain. 2005;6:455-458.
  • 8
    Kaniecki R, Totten J. Cervicalgia in migraine: Prevalence,clinical characteristics, and response to treatment. Cephalalgia. 2001;21:296(Abstract).
  • 9
    NIH Consensus Conference. Acupuncture. JAMA. 1998;280:1518-1524.
  • 10
    Larner AJ. Acupuncture use for the treatment of headache prior to neurological referral. J Headache Pain. 2005;6:97-99.
  • 11
    Manias P, Tagaris G, Karageorgiou K. Acupuncture in headache: A critical review. Clin J Pain. 2000;16:334-339.
  • 12
    Vernon H, McDermaid CS, Hagino C. Systematic review of randomized clinical trials of complementary/alternative therapies in the treatment of tension-type and cervicogenic headache. Complement Ther Med. 1999;7:142-155.
  • 13
    Linde K, Scholz M, Melchart D, Willich SN. Should systematic reviews include non-randomized and uncontrolled studies? The case of acupuncture for chronic headache. J Clin Epidemiol. 2002;55:77-85.
  • 14
    Melchart D, Linde K, Fischer P, et al. Acupuncture for recurrent headaches: A systematic review of randomized controlled trials. Cephalalgia. 1999;19:779-786.
  • 15
    Melchart D, Linde K, Fischer P, et al. Acupuncture for idiopathic headache (Cochrane review). Cochrane Database Syst Rev. 2001;1:CD001218.
  • 16
    Linde K, Streng A, Jurgens S, et al. Acupuncture for patients with migraine: A randomized controlled trial. JAMA. 2005;293:2118-2125.
  • 17
    Wonderling D, Vickers AJ, Grieve R, McCarney R. Cost effectiveness analysis of a randomised trial of acupuncture for chronic headache in primary care. BMJ. 2004;328:747.
  • 18
    Vickers AJ, Rees RW, Zollman CE, et al. Acupuncture for chronic headache in primary care: Large, pragmatic, randomised trial. BMJ. 2004;328:744.
  • 19
    Ceccherelli F, Facco E. Methodological problems on acupunture research in pain therapy. In: Capasso A, ed. Methodological Problems on Acupunture Research in Pain Therapy. Kerala, India: Research Signpost; 2005.
  • 20
    Facco E. Acupuncture in headache: State of the art. [World Federation of Acupuncture Societies. In proceedings: International symposium on acupuncture], 99-102. 2002. Rome, Paracelso.
  • 21
    ICD-10 Guide for Headaches. International headache classification committee. Cephalalgia. 1997;17:(Suppl 19) 1-82.
  • 22
    D’Amico D, Mosconi P, Genco S, et al. The migraine disability assessment (MIDAS) questionnaire: Trans lation and reliability of the italian version. Cephalalgia. 2001;21:947-952.
  • 23
    Maciocia G. The Practice of Chinese Medicine. London: Churchill Livingstone; 1994.
  • 24
    Van Nghi N. Pathogénie Et Pathologie Énergétique En Médecine Chinoise. Don Bosco: Marseille; 1977.
  • 25
    Ming Shunpei. Yang Shunyi Advanced Textbook of Traditional Chinese Medicine and Pharmacology. Beijing: New World Press; 1997.
  • 26
    Ganglin Yin. Zhenghua Liu Advanced Modern Chinese Acupuncture Therapy. Beijing: New World Press; 2000.
  • 27
    von Peter S, Ting W, Scrivani S, et al. Survey on the use of complementary and alternative medicine among patients with headache syndromes. Cephalalgia. 2002;22:395-400.
  • 28
    Zhao CH, Stillman MJ, Rozen TD. Traditional and evidence-based acupuncture in headache management: Theory, mechanism, and practice. Headache. 2005;45:716-730.
  • 29
    Krymchantowski AV. Refractoriness in migraine treatment: What are we talking about? Expert Rev Neurother. 2005;5:557-559.
  • 30
    McCormack PL, Foster RH. Rizatriptan: A pharmacoeconomic review of its use in the acute treatment of migraine. Pharmacoeconomics. 2005;23:1283-1298.
  • 31
    Stewart WF, Lipton RB, Whyte J, et al. An international study to assess reliability of the migraine disability assessment (MIDAS) score. Neurology. 1999;53:988994.
  • 32
    Stewart WF, Lipton RB, Kolodner K, Liberman J, Sawyer J. Reliability of the migraine disability assessment score in a population-based sample of headache sufferers. Cephalalgia. 1999;19:107-114.
  • 33
    Stewart WF, Lipton RB, Kolodner KB, Sawyer J, Lee C, Liberman JN. Validity of the migraine disability assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers. Pain. 2000;88:41-52.
  • 34
    Stewart WF, Lipton RB, Dowson AJ, Sawyer J. Development and testing of the migraine disability assessment (MIDAS) questionnaire to assess headache-related disability. Neurology. 2001;56:S20-S28.
  • 35
    Stewart WF, Lipton RB, Kolodner K. Migraine disability assessment (MIDAS) score: Relation to headache frequency, pain intensity, and headache symptoms. Headache. 2003;43:258-265.
  • 36
    Edmeads J, Lainez JM, Brandes JL, Schoenen J, Freitag F. Potential of the migraine disability assessment (MIDAS) questionnaire as a public health initiative and in clinical practice. Neurology. 2001;56:S29-S34.
  • 37
    Cabyoglu MT, Ergene N, Tan U. The mechanism of acupuncture and clinical applications. Int J Neurosci. 2006;116:115-125.
  • 38
    Zhang WT, Jin Z, Cui GH, et al. Relations between brain network activation and analgesic effect induced by low vs. high frequency electrical acupoint stimulation in different subjects: A functional magnetic resonance imaging study. Brain Res. 2003;982:168-178.
  • 39
    Gracely RH. Charisma and the art of healing: Can non specific factors be enough? Devor M, Rowbotham MC, Wiesenfeld-Hallin Z. Proceedings of the 9th World Congress on Pain. Progress in Pain Research and Management. Seattle, JASP Press. 2000;16:1045-1067.